Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 reverse transcriptase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trypanosoma congolense | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Schistosoma mansoni | hypothetical protein | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Trypanosoma brucei | RNA helicase, putative | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Plasmodium yoelii | integrase-related | Get druggable targets OG5_139608 | All targets in OG5_139608 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | integrin alpha 3 | 0.0485 | 0.4771 | 0.7713 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0042 | 0.0047 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.0665 | 0.0981 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0616 | 0.6171 | 0.9723 |
Echinococcus granulosus | integrin alpha ps | 0.0283 | 0.2623 | 0.4206 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0042 | 0.0047 | 0.5 |
Echinococcus multilocularis | geminin | 0.0151 | 0.1212 | 0.1902 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0042 | 0.0047 | 0.5 |
Echinococcus granulosus | integrin alpha ps | 0.0136 | 0.1048 | 0.1634 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1173 | 0.1131 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0038 | 0 | 0.5 |
Schistosoma mansoni | integrin alpha-ps | 0.0148 | 0.1173 | 0.1787 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0129 | 0.013 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0038 | 0 | 0.5 |
Echinococcus granulosus | geminin | 0.0151 | 0.1212 | 0.1902 |
Brugia malayi | Integrin alpha cytoplasmic region family protein | 0.0478 | 0.4702 | 0.739 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0042 | 0.0047 | 0.5 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0042 | 0.0047 | 0.5 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0042 | 0.0047 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0129 | 0.0133 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0616 | 0.6171 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0136 | 0.1048 | 0.1589 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 0.0129 | 0.0082 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.1048 | 0.1006 |
Loa Loa (eye worm) | hypothetical protein | 0.0349 | 0.3321 | 0.3289 |
Schistosoma mansoni | hypothetical protein | 0.0151 | 0.1212 | 0.1849 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0632 | 0.6346 | 1 |
Echinococcus multilocularis | integrin alpha ps | 0.0283 | 0.2623 | 0.4206 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0616 | 0.6171 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0042 | 0.0047 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0129 | 0.013 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 0.0129 | 0.0133 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.005 | 0.0129 | 0.013 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0129 | 0.0133 |
Echinococcus multilocularis | integrin alpha ps | 0.0283 | 0.2623 | 0.4206 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0042 | 0.0047 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.01 | 0.0665 | 1 |
Echinococcus multilocularis | integrin alpha 3 | 0.0485 | 0.4771 | 0.7713 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0042 | 0.0047 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0151 | 0.1212 | 0.1849 |
Schistosoma mansoni | integrin alpha-ps | 0.0283 | 0.2623 | 0.409 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 0.0129 | 0.013 |
Loa Loa (eye worm) | hypothetical protein | 0.0478 | 0.4702 | 0.4677 |
Schistosoma mansoni | integrin alpha | 0.0632 | 0.6346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0496 | 0.4896 | 0.4872 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 0.0129 | 0.0133 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0042 | 0.0047 | 0.5 |
Echinococcus multilocularis | integrin alpha ps | 0.0136 | 0.1048 | 0.1634 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | > 200 uM | Cytotoxicity against mock-infected MT-4 cells. | ChEMBL. | 10052969 |
CC50 (functional) | > 200 uM | Cytotoxicity against mock-infected MT-4 cells. | ChEMBL. | 10052969 |
EC50 (functional) | = 0.96 uM | Concentration of the compound required to achieve 50% protection of MT-4 cells from HIV-1-induced cytopathogenicity. | ChEMBL. | 10052969 |
EC50 (functional) | = 0.96 uM | Concentration of the compound required to achieve 50% protection of MT-4 cells from HIV-1-induced cytopathogenicity. | ChEMBL. | 10052969 |
IC50 (binding) | = 0.9 uM | Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%. | ChEMBL. | 10052969 |
IC50 (binding) | = 0.9 uM | Concentration required to inhibit the HIV-1 reverse transcriptase activity by 50%. | ChEMBL. | 10052969 |
Selectivity index (functional) | > 208 SI | Selectivity index measured as the ratio of CC50 / EC50. | ChEMBL. | 10052969 |
Selectivity index (functional) | > 208 SI | Selectivity index measured as the ratio of CC50 / EC50. | ChEMBL. | 10052969 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 10052969 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.